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Abstract
The melanocortin system directs diverse physiological functions from coat color to body weight homoeostasis. A
commonality among melanocortin-mediated processes is that many animals modulate similar processes on a
circannual basis in response to longer, summer days, suggesting an underlying link between circadian biology and
the melanocortin system. Despite key neuroanatomical substrates shared by both circadian and melanocortinsignaling pathways, little is known about the relationship between the two. Here we identify a link between
circadian disruption and the control of glucose homeostasis mediated through the melanocortin-4 receptor
(Mc4r). Mc4r-deficient mice exhibit exaggerated circadian fluctuations in baseline blood glucose and glucose
tolerance. Interestingly, exposure to lighting conditions that disrupt circadian rhythms improve their glucose
tolerance. This improvement occurs through an increase in glucose clearance by skeletal muscle and is food intake
and body weight independent. Restoring Mc4r expression to the paraventricular nucleus prevents the
improvement in glucose tolerance, supporting a role for the paraventricular nucleus in the integration of circadian
light cues and metabolism. Altogether these data suggest that Mc4r signaling plays a protective role in minimizing
glucose fluctuations due to circadian rhythms and environmental light cues and demonstrate a previously
undiscovered connection between circadian biology and glucose metabolism mediated through the melanocortin
system.

The melanocortin system directs diverse physiological functions from coat color to body weight
homoeostasis. A commonality among melanocortin-mediated processes is that many animals modulate
such processes on a circannual basis in response to longer, summer days, suggesting an underlying link
between circadian biology and the melanocortin system. A growing body of literature links biological
rhythms to metabolism. Circannual (seasonal) rhythms of food intake, energy expenditure, and body
weight are associated with day length (1). Circadian (daily) rhythms, which are controlled by photicsensitive circuits in the hypothalamic suprachiasmatic nuclei (SCN), orchestrate metabolic processes
that, when disrupted, can lead to the development of the metabolic syndrome (2–4). However, little is
known of the mechanism(s) that link circadian light cues to metabolism.
Multiple nutrient and hormonal signals convey information about energy status to the brain through the
melanocortin system, and in particular through the melanocortin-4 receptor (Mc4r), to regulate energy
balance (5). Thus, Mc4r-deficient humans and rodents are hyperphagic and obese and have impaired
glucose tolerance (6, 7). Mc4r may also be important in mediating information about circadian light
cues. When light stimulates the retina, photic information is relayed via the retinohypothalamic tract to
the SCN and onto key metabolic areas that express Mc4r such as the arcuate nucleus via the
melanocortin transmitter, α-MSH (8), and the paraventricular nucleus (PVN) (9). The overlap between
anatomical pathways and physiological effects raises the possibility that Mc4r may function as an
integrator of circadian light cues with the control of energy balance. Here we provide data that support
the conclusion that Mc4r integrates circadian light cues with glucose metabolism.

Materials and Methods
Animals
LoxTbMc4r (stock number 006414; Jackson laboratory) knockout (KO) mice and wild-type littermate
controls (WT) were ordered from Jackson laboratory and bred in-house. WT mice (C57BL/6J; stock
number 000664) were ordered from the Jackson laboratory. Ob/ob mice (stock number 000632) were
ordered from The Jackson Laboratory. Sim1-Cre mouse models were kindly provided by Dr Joel Elmquist
(University of Texas Southwestern, Dallas, Texas) and bred in-house to obtain homozygous loxTbMc4r
(KO−), which lack Mc4r expression globally, and homozygous loxTbMc4r mice carrying at least one Sim1Cre allele (KO+) as well as Sim1-Cre WT littermates (WT+), as previously described (10). All mice were
males unless otherwise mentioned in text. Mice were singly housed and fed an ad libitum standard
chow diet (Teklad number 7002, 18% calories from fat, 3.1 kcal/g) unless otherwise mentioned. To
create obese WT animals, singly housed mice were fed a 45% high-fat diet (Research Diets number
D12451, 45% fat, 4.54 kcal/g). For all studies, groups were age matched but otherwise divided to ensure
equal body weights among similar genotyped animals. The total number per experiment is noted in each
experimental figure legend. The investigators were not blinded to the animals’ genotype or light
condition. All studies were approved by and performed according to the guidelines of the Institutional
Animal Care and Use Committee of the University of Cincinnati.

Light protocols
Mice were housed in a standard vivarium room with a minimum of 80 lux during the light period.
Standard 12-hour light, 12-hour dark (LD) consisted of 12 hours of light followed by 12 hours of dark.
Constant light (LL) occurred in a neighboring room with otherwise similar environmental conditions.
Similarly, a 2L2D cycle was achieved by using repeated cycles of 2 hours of light followed by 2 hours of
dark (2L2D).

Automated phenotype analysis
Animals were singly housed, maintained on the appropriate light-dark cycle, and placed into an
automated system to measure data in increments of 5–45 minutes (Phenotyping Systems International
Group). Activity counts (via beam break) and feeding patterns were measured simultaneously over the
course of the 1–2 weeks. Data analysis began after animals had acclimated to the metabolic chambers
for at least 48 hours. For consistency, the first 24 hours of data in the chamber or after a light switch
were excluded from analysis to remove differences in habituation.

Twenty-four-hour fasting glucose levels
Animals were habituated to handling by 2+ weeks of at least twice a week gentle handling prior to
testing. Animals were fasted for 12 hours (overnight) prior to the first blood glucose measurement at
Zeitgeber time (ZT) 2. Blood glucose was measured by glucometer every 4 hours on each animal by tail
clip and gentle handling. Animals remained fasting until all measures were complete (eg, ZT 22).

Glucose tolerance test
Animals were fasted for 6 hours prior to an ip injection of 25% dextrose at a dose of 8 μl/g at ZT 6. Blood
glucose was measured by tail clip and gentle handling by glucometer prior to glucose injection (time 0),
and at 15, 30, 60, and 120 minutes after injection. Animals were excluded from analysis based on

preestablished criteria, eg, if blood glucose did not rise significantly over the 2-hour period, indicating a
failed glucose injection.

Catheterization for hyperinsulinemic-euglycemic clamps
After 2 weeks of LD or LL exposure, mice underwent surgery for the hyperinsulinemic-euglycemic clamp.
Mice were catheterized in the left common carotid artery and right jugular vein as previously described
(11). Immediately after the surgery, animals were given sc injections of buprenorphin (0.28 mg/kg
Buprenex; Reckitt Benckiser Healthcare), meloxicam (0.25 mg/100 g body weight; Metacam), and 1 mL
warm saline.

Hyperinsulinemic-euglycemic clamp
After 5–10 days of recovery from surgery, hyperinsulinemic-euglycemic clamps were performed as
previously described (11). On the day of the clamp procedure, mice were fasted for 4 hours. At time 0
(∼10:00 am; ZT 4), a primed (2.5 μCi) continuous infusion (0.05 μCi) of [3-3H]glucose (PerkinElmer Life
Sciences) was started and continued throughout the clamp. One hundred twenty minutes after the start
of the [3-3H]glucose infusion, insulin was infused at a rate of 3 mU/kg · min, and exogenous glucose was
infused to maintain blood glucose levels between 130 and 150 mg/dL. A bolus of 50 μL of 2-[14C]2deoxyglucose ([14C]2-DG; 0.013 mCi) was infused into the jugular vein 40 minutes prior to the end of the
clamp procedure to assess tissue-specific glucose uptake. Mice were euthanized with an injection of
sodium pentobarbital and tissues collected. Plasma and tissues were stored at −80°C for analysis. Blood
sampling, glucose turnover, and tissue-specific glucose uptake calculations were performed as
previously described (12).

Statistics
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software). Statistical
significance was determined by unpaired Student’s t test, one-way ANOVA followed by Tukey’s multiple
comparison post hoc test, two-way ANOVA followed by Bonferroni’s multiple comparison post hoc test,
or a repeated-measures ANOVA followed by Bonferroni’s multiple comparison post hoc test as
referenced in the text. Results were considered statistically significant when P < .05.

Results
Mc4r-deficient mice have amplified daily variations in baseline blood glucose and
glucose tolerance
Circadian variations in circulating glucose and glucose tolerance occur in both rodents and humans (13–
16). In fasting conditions, WT mice maintained under a normal LD cycle demonstrate a rise in the fasting
blood glucose levels at the end of the light phase followed by a fall at the end of the dark phase (Figure
1A) as previously shown (14–16). However, mice lacking Mc4r (hereafter KO) display an exaggerated
fluctuation in daily fasting glucose compared with WT littermate controls (Figure 1A, P < .001).

Figure 1 Twenty-four-hour baseline fasting glucose in C57BL/6J and Mc4R-deficient mice housed in a standard
light-dark (LD) cycle or continuous light exposure (LL). A, Baseline fasting glucose levels in WT C57BL/6J mice (WT;
black symbols, n = 11) and Mc4R-deficient mice (KO; white symbols, n = 10) housed in a standard LD cycle (solid
lines). B, Baseline fasting glucose levels in WT (black symbols, n = 10) and KO (white symbols, n = 10) mice housed
in LL (dashed lines). Data are expressed as mean ± SEM and double plotted (repeated measures two way ANOVA).
Asterisks indicate significant posttest differences: *, P < .05; **, P < .01; ***, P < .001.
In addition to fasting baseline glucose, daily variation in glucose tolerance was also significantly altered
in the KO compared with the WT, with the KO having a significantly amplified fluctuation in glucose
tolerance (Figure 2A, P < .01). Glucose tolerance and baseline fasting glucose was similar between the
genotypes during the early morning hours (eg, ZT 1) but became significantly different toward the end of
the light phase (eg, ZT 11) (Figure 2A, P < .01; Figure 2B, P < .001).

Figure 2 Daily variation in glucose tolerance of WT and KO mice. A, Glucose tolerance of both WT (black symbols)

and KO (white symbols) are markedly improved at ZT 1 (dashed lines). Glucose tolerance is impaired at ZT 11 (solid
lines) in both genotypes; however, KO mice have more of an impairment in glucose tolerance (area under the
curve inset). Repeated-measures ANOVA was used for glucose tolerance test and an unpaired, two-sided t test for
area under the curve (AUC). B, Baseline fasting glucose levels in WT (black) and KO (white) mice at ZT 1 and ZT 11
(cross-over design, two-way ANOVA, n = 21/group).

Acute exposure to constant light reduces daily variations in blood glucose and
improves glucose tolerance in KO mice without altering body weight or food intake
Lesioning the SCN or disrupting its function by exposing mice to constant light (17) will lead to a blunting
of glucose rhythms and insulin sensitivity (14, 18). To determine how the KO mouse would respond to
desynchronized conditions, we housed KO mice in constant light (LL). In contrast to the KO mice housed

under standard LD, KO mice housed in LL for a week displayed similar fasting glucose levels to WT mice
(Figure 1B).
To investigate the role of Mc4r in the control of glucose homeostasis, we performed a glucose tolerance
test. Although the glucose tolerance of WT mice was unaffected by 1 week of LL exposure (Figure 3A),
KO mice had significantly improved glucose tolerance after LL (Figure 3B, P < .05). This effect occurred
independently of body weight because the 1 week of LL exposure was insufficient to lead to body weight
changes in KO mice (data not shown). A similar improvement in glucose tolerance was also observed in
female KO mice (Supplemental Figure 1, P < .001).

Figure 3 Glucose tolerance of WT and KO mice after 1 week of LL (dashed line) within the automated phenotyping

system or 1 week of LD exposure (solid line) in standard housing. A, WT mice have no significant change of glucose
tolerance after 1 week of LL exposure [repeated measures, two way ANOVA for glucose tolerance test,
nonsignificant F (1, 13) = 0.9842, P = .34, unpaired, two sided t test for area under the curve (AUC), nonsignificant
(ns) P = .44; WT LD (n = 8), WT LL (n = 7)]. B, KO mice have significantly improved glucose tolerance after 1 week of
LL exposure [repeated measures, two way ANOVA for glucose tolerance test, significant effect of the LL exposure, F
(1, 14) = 6.201, P < .05, Bonferroni posttest, unpaired, two sided t test for area under the curve (AUC), P < .05; KO
LD (n = 8); KO LL (n = 8)]. Data are expressed as mean ± SEM.

To assess the impact of constant light on food intake and activity, KO and WT mice were maintained for
1 week in LD and then changed to LL for an additional week. When maintained on LD, KO mice had
significantly lower physical activity (Supplemental Figure 2A, P < .05) than WT, although both exhibited
similar dark-light fluctuations. During LL, WT mice had significantly reduced daily locomotor activity (P
< .001), whereas there was no change in KO mice. Food intake (Supplemental Figure 2B) did not differ
between the 1-week LL and the 1-week LD conditions for either genotype.

Improvement in glucose tolerance of Mc4r-deficient mice in LL is not due to
obesity
To determine whether the LL-induced improvement in glucose tolerance was due to the obese state of
the KO mice as opposed to a specific loss of Mc4r signaling, we assessed the glucose tolerance of other
obese models exposed to LL. LL did not affect glucose tolerance of diet-induced obese WT mice
(Supplemental Figure 3) or genetically obese ob/ob mice (Supplemental Figure 4).

Long-term exposure to constant light improves glucose tolerance and suppresses
weight gain in Mc4r-deficient mice
Although light therapy can lead to weight loss in obese humans (19), long-term LL combined with a highfat diet disrupts circadian rhythms and leads to weight gain in rodents (20). To test the effect of long
term expose to LL on body weight and food intake in chow-fed animals, KO mice (8–12 wk old) and their
WT littermates were maintained on LD or LL for 24 days. As expected, KO mice gained more weight than
WT mice in both LD and LL. However, weight gain of KO mice was significantly attenuated in the LL
relative to the LD condition (Table 1, P < .05). KO mice ate significantly more calories than WT mice in LD
(P < .05) but not LL conditions. Within KO mice, there was no significant difference in caloric intake
between LD and LL (Table 1). Similar to the acute LL exposure, long-term exposure to LL (eg, up to 3 wk)
improves glucose tolerance, at least in part by increasing the insulin-dependent glucose uptake in the
KO mice (Figure 4).

Figure 4 Hyperinsulinemic-euglycemic clamp in KO and WT littermates during LD or LL. A, Blood glucose levels
were maintained at comparable levels for all groups. B, During steady-state conditions (final 30 min of the clamp),

the KO LD mice required significantly less glucose compared with all other groups to maintain euglycemia. Notably,
KO LL had a similar glucose infusion rate as WT mice and required more glucose than KO LD. C, Glucose infusion
rate in WT mice after 3 weeks of LD or LL. D, Glucose infusion rate in KO mice after 3 weeks of LD or LL. KO mice
had a significantly higher rate of glucose infusion on LL than on LD (P < .05). E, During baseline conditions, there
were no differences in endogenous glucose production (EGP). During the final 30 minutes, EGP was suppressed in
all groups. F, During baseline conditions, there were no differences in glucose clearance. During the final 30
minutes, glucose clearance of WT LD and KO LL was significantly higher than in KO LD. G, There were no significant
changes in EGP among groups. H, The insulin infusion significantly increased glucose clearance over baseline
conditions in all groups except the KO LD. Moreover, KO LL mice increased their glucose clearance to a level similar
to that of WT mice. I, [14C]2-DG uptake was significantly enhanced in KO LL compared with WT LL in the
gastrocnemius and soleus muscles, with a trend toward increased uptake in heart and brain. (P < .05). *, P < .05;
***, P < .001 (repeated measures, two way ANOVA; KO LD, n = 7, except gastrocnemius, n = 6; WT LL, n = 6; WT LD,
n = 8; KO LL, n = 8). Data are expressed as mean ± SEM.

Table 1 Effects of Constant Light in WT and Mc4r-Deficient Mice

Change in body weight, g ± SEM

Food intake, kcal ± SEM

Light Cycle

WT

Mc4r Deficient

P Value

LD

2.83 ± 0.43 (n = 7)

9.84 ± 0.51 (n = 6)

<.001

LL

2.27 ± 0.50 (n = 5)

6.97 ± 1.10 (n = 7)

<.001

LD

298.68 ± 21.58 (n = 7)

459.93 ± 23.21 (n = 6)

<.01

LL

334.37 ± 17.15 (n = 5)

405.19 ± 40.03 (n = 8)

ns

Abbreviation: ns, not significant.

Constant light increases insulin-dependent glucose uptake in muscle of Mc4rdeficient mice
We performed hyperinsulinemic-euglycemic clamps in KO and WT littermate mice after 3 weeks of LD or
LL exposure. Glucose was infused to achieve a stable blood glucose level of 150 mg/dL (Figure 4A).
Consistent with the glucose tolerance tests, there was no difference in the glucose infusion rate in WT
mice after LD or LL exposure (Figure 4, B and C). KO mice in LL required a significantly higher glucose
infusion rate to achieve stable plasma glucose levels compared with KO mice in LD, indicating an
increase in whole-body insulin sensitivity (Figure 4, B and D, P < .05). Constant light had no effect on
endogenous glucose production (Supplemental Figure 5, A, C) but increased glucose clearance in KO but
not WT mice (Supplemental Figure 5B and D, P < .05). This increase in clearance was associated with an
increased 14C-2-DG uptake in muscle (Supplemental Figure 5E, P < .05). These data suggest that the
improved glucose tolerance by the KO in LL is due to an increase in insulin sensitivity at the level of the
skeletal muscle.

Exposure to other, nonentraining light cycles improves glucose tolerance in Mc4rdeficient but not WT mice
To determine whether the changes in glucose homeostasis were specific to constant light exposure or
whether they could be elicited using other circadian disruption protocols, we exposed mice to a
nonentraining 4-hour day, or 2L2D cycle, for 10 days. Similar to what we observed during the LL

conditions, KO mice in 2L2D exhibited an improvement in glucose tolerance (Supplemental Figure 6, P
< .05).

Reactivation of Mc4r in the PVN prevents LL-induced improvements in glucose
tolerance
Lastly, we hypothesized that Mc4r expression in the PVN represented a key integration site for light and
metabolic signaling. Using a Sim1-Cre reactivation model (10), we exposed 18- to 28-week-old loxTB
Mc4r-deficient (eg, KO−), Sim1-Cre loxTB (eg, KO+), and age-matched wild-type littermate controls
(Sim1-Cre WT; eg, WT+) to 2L2D for 2 weeks and then assessed glucose tolerance. As described (10), this
model reactivates Mc4r expression within the PVN, supraoptic nucleus, and amygdala. Whereas 2L2D
resulted in an improvement in glucose tolerance in the whole-body KO−, reactivation of Mc4r in the PVN
(eg, KO+) severely attenuated the improvement (Figure 5).

Figure 5 Glucose tolerance of Sim1-Cre reactivation mice after 2 weeks of 2L2D exposure (dashed lines) or 2
weeks of the LD exposure (solid lines). A, Neither WT+ mice nor KO+ mice have significant change of glucose
tolerance after 2 weeks of 2L2D exposure. However, KO− mice have a robust improvement in glucose tolerance. B,
Area under the curve (AUC) calculations for glucose tolerance indicates that only KO− had a significant
improvement in glucose metabolism after 2 weeks of 2L2D exposure (n = 7–10/group). Data are expressed as
mean ± SEM.

Discussion
Central nervous system sensing of available energy and the time of day is key for the normal control of
energy balance. Aberrant amounts of either available nutrients or light exposure disrupt metabolic
control and exacerbate susceptibility to develop the metabolic syndrome. Our data provide evidence
that the melanocortin system, classically associated to the control of nutrient availability, is also
involved in regulating the circadian control of glucose homeostasis. Specifically, these data suggest that
Mc4r signaling, including that within the PVN, plays a protective role in minimizing glucose fluctuations
due to circadian rhythms and environmental light cues. Likewise, we propose that circadian fluctuations
contribute to the glucose intolerance of Mc4r-deficient mice (see schematic in Figure 6).

Figure 6 Mechanistic summary. Top panel, During a normal LD cycle, Mc4r expression in the PVN attenuates the

impact of the normal output from the SCN on glucose homeostasis. Loss of Mc4r expression prevents this
attenuation, leading to an exaggerated impact of the light cues on baseline glucose and glucose tolerance. Bottom
panel, During constant light, the normal output from the SCN that regulates baseline glucose and glucose tolerance
is disrupted, leading to a marked improvement in glucose tolerance in Mc4r KO mice. AgRP, Agouti related protein;
POMC, proopiomelanocortin.

Most organisms have evolved to use light cues, and yet relatively little is known about how circadian
rhythms go on to affect the multitude of physiological processes that are necessary for daily survival.
From an evolutionary perspective, there is a benefit to closely associating photic cues with the
melanocortin system. By using environmental light as a cue, animals can anticipate and predict the
onset of day or night as well as the changing of the seasons. Circadian and circannual cues such as these
are important indicators for the avoidance of predators, reproductive success, and the efficient use of
metabolic resources. Interestingly, the melanocortin system is ideally posed to regulate many of these
circadian and light-associated characteristics: coat color (21) (associated with the Mc1r), meal
entrainment (22) (Mc3r), fat storage and glucose tolerance (21) (Mc3r, Mc4r), and sexual function (21)
(Mc4r). Indeed, light directly regulates some aspects of the melanocortin system, including receptors
responsible for pigmentation (21) and is linked to others by indirect mechanisms (23, 24).
Circadian fluctuations in the control of glucose homeostasis have been well documented in rodents and
humans (14, 15, 25–27). This control requires the molecular (15) and neuroanatomical integrity (28) of
the central clock, and their disruption leads to impaired glucose control. The exaggerated circadian
fluctuations in baseline blood glucose and glucose tolerance exhibited by mice lacking Mc4r signaling
demonstrate that rhythms, and the central clock, may be subjected to restraint by other neural systems.
Our results demonstrate that circadian disruption, as caused by disruptive environmental light exposure,
in combination with lack of Mc4r signaling, results in an improvement in glucose tolerance independent
of changes in body weight and food intake. This selective regulation of glucose homeostasis in response
to circadian disruption is surprising, given the well-known critical role of Mc4r in the control of feeding

and fat mass. These data point to the unique role of Mc4r in regulating glucose homeostasis in response
to circadian disruption and suggest that other central and/or peripheral factors are important for the
changes in body weight and feeding associated with circadian disruption (20, 29, 30).
Taken together, these results, and previous reports on the neuroanatomical distribution of Mc4r
expression, suggest that an integration site for light and the melanocortin system is downstream of the
SCN, in sites that include the PVN. Indeed, we found no evidence to support the possibility that
behavioral rhythms are directly altered by Mc4r mutation, suggesting that the SCN itself is not the
critical region involved in the glucose response to light cues mediated by Mc4r signaling. Moreover, the
SCN of mice, rats, and humans do not express Mc4r (31–33). However, the SCN, through projections to
the PVN, plays a significant role in the control of glucose homeostasis (34). Reactivating Mc4r in the PVN
and restoration of a wild-type glucose regulation response supports the conclusion that the PVN is
relatively more important than the SCN for our observed changes in glucose. However, Sim1-Credependent Mc4r reactivation is not specific to PVN (10), and therefore, a potential contribution of other
brain regions coexpressing Sim1 and Mc4r to the circadian control of glucose cannot be excluded.
Notably, Sim1-Cre Mc4r reactivation does not lead to improved glucose tolerance but instead nullifies
the effect of the light exposure. These data suggest that although Mc4r in Sim1-expressing neurons,
including those in the PVN, are critical for the modulation of glucose during circadian disruption, it is not
principally involved in regulating other aspects of metabolism during circadian disruption (eg, feeding).
The precise mechanism(s) by which Mc4r signaling controls glucose metabolism in response to circadian
signals remains to be determined, although potential mechanisms could involve preautonomic neural
circuits and/or neuroendocrine axes.
These results have important implications for humans. More and more, societies are running around the
clock, leading to more people being active (and working) during the evening as well as experiencing
increased light exposure at night. Mounting evidence suggests that these events can lead to circadian
disruption, which is associated with obesity and cardiometabolic diseases (35, 36). However, it remains
unclear exactly how circadian disruption translates into metabolic impairment. As others have noted
(37), the combination of obesity and poor metabolic control leads to detrimental health, thus making it
crucial to use a multiapproach strategy to fight disease. We expect that continued research focusing on
how neural circuits, including the melanocortin system, and circadian light cues are connected can lead
to novel approaches to treatment metabolic diseases such as obesity and diabetes.
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Abbreviations
[14C]2-DG 2-[14C]2-deoxyglucose
KO knockout
LD standard 12-hour light, 12-hour dark
2L2D repeated cycles of 2 hours of light followed by 2 hours of dark
LL constant light exposure
Mc4r melanocortin-4 receptor
PVN paraventricular nucleus
SCN suprachiasmatic nuclei
WT wild type
ZT Zeitgeber time.
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